An in silico approach to design a novel multi-epitope peptide vaccine against Helicobacter Pylori

سال انتشار: 1399
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 384

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ICIBS01_280

تاریخ نمایه سازی: 2 آذر 1399

چکیده مقاله:

Introduction & Objectives: Helicobacter pylori, the most common human infectious agent, is a gram-negative bacterium that colonizes in the stomach and causes gastritis, peptic ulcers, adenocarcinoma, and MALT (mucosa-associated lymphoid tissue) lymphoma. This bacterium which has recognized as carcinogen by the World Health Organization (WHO), has infected 50% of the world population on average. Although because of its high prevalence rate and antibiotics resistance, development of a vaccine has been accepted as an efficient strategy in prevention of mentioned cancers, it has remained as a challenge so far and today immunoinformatics is a promising way that helps to solve this problem.Methods: In this study, three H. Pylori antigens, including UreB, HpaA, and NapA were selected which have an important role in its pathogenicity or colonization. Since the T CD4⁺ cells are the most important of the immune system cells against H. Pylori, so their potential immunodominant T CD4⁺ epitopes were selected by four relevant servers including IEDB, MHC2Pred, MHCPred, and RANKPEP and after evaluation by IFNepitope server, were joined to each other by KK and GPGPG linkers. As adjuvant, flagellin D0 and D1 domains were added to each side of the construct by a flexible linker, EAAAK, to increase its immunity. Then the designed vaccine was evaluated in multiple aspects.Results: The final construct was estimated as antigenic (0.93) and nonallergenic with appropriate solubility (0.63), molecular weight (64581.40), isoelectric pH (9.37), and instability index (29.32).Conclusion: Based on the current study, this vaccine can serve as a promising anti-H. Pylori vaccine and gastric cancer-preventive candidate.

نویسندگان

Elham Jafari Zandieh

Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran

Shirin Mahmoodi

Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran